Abstract-Abnormalities in whole blood viscosity (WBV) have been implicated in hypertension. This study analyzes relations between WBV and blood pressure in the Strong Heart Study population of American Indians. We examined 676 participants (489 women, age 62Ϯ7 years) without prevalent cardiovascular disease or use of antihypertensive medications, digoxin, or aspirin. WBV was calculated from hematocrit and plasma protein concentration, at a shear rate of 208 seconds
Abnormalities in blood viscosity have been implicated in a number of cardiovascular diseases. [1] [2] [3] Given the direct role of whole blood viscosity (WBV) in determining vascular resistance, recognized by Poiseuille, 4 there is interest in possible relations between viscosity and hypertension. [5] [6] [7] [8] [9] [10] [11] A study performed in normotensive subjects 6 demonstrated an independent association of WBV with diastolic or mean blood pressure, but not with systolic pressure, giving support to further research to investigate possible relations of WBV with hypertension and other cardiovascular risk factors. However, most mechanisms remain unclear. 10 Unfortunately, direct determination of in vitro WBV is technically demanding and difficult to apply in epidemiological studies. We have previously shown that up to 83% of variability of WBV could be explained by microhematocrit and total plasma protein concentration (as a surrogate of plasma viscosity) over a range of shear rates from 0.1 to 208 seconds Ϫ1 . 6 Relations between blood pressure and rheological components or WBV have rarely been studied in general populations. 12, 13 The Strong Heart Study is a population-based longitudinal survey in American Indians, an ethnic group with higher prevalence of obesity and diabetes than in previous studies on WBV, which provides an opportunity to investigate cross-sectional associations between blood pressure and estimated WBV in the presence of these increasingly prevalent cardiovascular risk factors, without confounding by medication effect or consequences of overt cardiovascular disease. For simplicity, the study has been performed only considering viscosity at a shear rate of 208 seconds Ϫ1 , approximating the shear stress in arterial and arteriolar circulation.
Methods

Population
The Strong Heart Study is a population-based longitudinal survey of cardiovascular risk factors and disease in American Indians from 3 communities in Arizona, 7 in Southwestern Oklahoma, and 3 in South and North Dakota, as previously reported. 14 -18 The phase 3 examination was conducted in 1998 to 1999 and included hematocrit and plasma protein determinations, not performed during phase 1 or 2, in 3680 participants, with 1793 hypertensive subjects and 1887 normotensive subjects. Among these participants, 2491 (67%) were using cardioactive medications, including diuretics, ␤-blockers, angiotensin-converting enzyme inhibitors, Ca-channel blockers, other antihypertensive drugs, digoxin, or aspirin and were excluded from this study. Among the remaining subjects, 513 with prevalent cardiovascular disease (including adjudicated coronary heart disease, congestive heart failure, valve disease, and cerebrovascular or peripheral vascular disease) at the time of this evaluation were also excluded. A total of 676 participants, including obese and diabetic individuals, were finally selected (489 women, aged 62Ϯ7 years), 188 from Arizona, 249 from Oklahoma, and 239 from North/ South Dakota.
Obesity and central fat distribution were defined by National Institutes of Health guidelines. 19 Diabetes was identified by American Diabetes Association criteria. 20 Diagnosis of untreated hypertension was based on measured blood pressure Ն140 mm Hg systolic and/or Ն90 mm Hg diastolic. Seated blood pressure was measured 3 times during the clinic visit, over a period of Ϸ10 minutes, according to standardized procedures used for the study.
Methods
Fasting plasma glucose and insulin, as well as other blood tests, were measured by standard methods. 16 WBV was determined in centipoises (cP) at a shear rate of 208 seconds Ϫ1 , using the following equation 6 :
This equation has been validated by comparison with direct WBV measurements (rϭ0.92, nϭ50) in white and black adults, but not in American Indians, and by demonstrating that the degree of error introduced by the predictive equation is less than the year-to-year variability of directly measured WBV. 6 This method has already been used for population-studies. 21 
Statistical Analysis
Data were analyzed using SPSS 11.0 software (SPSS, Chicago, Ill). Data are expressed as meanϮSD. Descriptive statistics were obtained using standard normal or 2 distributions (with Monte Carlo method for computation of exact 2-tailed ␣-value, when appropriate). In hypotheses-testing analyses, the 3 field centers, Arizona, South and North Dakota, and Oklahoma, were represented by indicator variables. Relations between blood pressure and WBV or its principal determinant, hematocrit, were studied using ANCOVA and multiple linear regression analysis by enter or step-wise procedures and tolerance tests to allow only models with low degrees of collinearity (tolerance Ͼ0.70). The null hypothesis was rejected at 2-tailed PՅ0.05.
Results
Participant Characteristics
Diabetes, obesity, and central fat distribution were significantly more prevalent in Arizona (59%, 68%, and 86%, respectively) than in North/South Dakota (33%, 33%, and 71%) and Oklahoma (40%, 48%, and 73%; all PϽ0.001). In contrast, smoking was more frequent in North/South Dakota (43%) than in Arizona (15%) or Oklahoma (30%; PϽ0.0001).
Among participants, 324 (48%) were obese, 233 (35%) were overweight, and 514 (76%, 418 women) had central fat distribution, based on National Institutes of Health partition values for waist girth. Diabetes was found in 288 (43%, 214 women) and untreated hypertension in 128 (19%, 88 women); 205 participants (135 women) were current smokers and 222 (145 women) were former smokers.
Blood pressure was 149/82Ϯ12/11 mm Hg in hypertensive as opposed to 120/71Ϯ11/8 mm Hg in normotensive participants. Only 31 hypertensive persons (24%) had diastolic blood pressure Ն90 mm Hg, and only 6 (5%) had diastolic pressure Ն100 mm Hg. Thus, untreated arterial hypertension in this population sample was mainly isolated systolic; diastolic hypertension, when present, was mild. Hypertensive participants were similar in age (63Ϯ7 versus 62Ϯ7 years) and had slightly higher body mass index (32Ϯ6 versus 30Ϯ7 kg/m 2 ; Pϭ0.06) compared with normotensive participants.
Correlates of WBV
Hematocrit and WBV were higher in men and in the presence of obesity, central fat distribution, and current smoking, whereas no differences were found between hypertensive and normotensive or diabetic and nondiabetic participants (Table  1) . Plasma protein concentration was also higher in men than in women (Table 1) . Hematocrit and WBV were higher in Oklahoma than in the other centers, whereas plasma protein concentration was slightly higher in the Dakotas, both in men and women. These differences were maintained after controlling for age and presence of diabetes (all, 0.01ϽPϽ0.004; Table 2 ).
After adjusting for gender, age, center, smoking status, presence of obesity, diabetes, and plasma creatinine (as a raw measure of renal function), systolic blood pressure was negatively related to WBV (PϽ0.01; Table 3 , top panel), and hematocrit (␤ϭϪ0.10; PϽ0.02), whereas no relation was found with diastolic blood pressure ( Table 3 , middle panel). Lower WBV was more strongly related to higher pulse pressure (PϽ0.003), independent of other significant associations, including older age, greater body mass index, female gender, presence of diabetes, and center effect (Table 3 , bottom panel, with a similar independent negative relation between hematocrit and pulse pressure; PϽ0.006). 
WBV and Arterial Hypertension
1).
Pulse pressure, the component of blood pressure most related to WBV in this population, was examined separately in hypertensive and normotensive participants, using WBV and covariates, in stepwise regression model (Table 4 ). In individuals with arterial hypertension, pulse pressure was higher in Oklahoma and diabetic participants, and was directly related to age and female gender. In contrast, in normotensive individuals, pulse pressure was not influenced by diabetes but was related to higher body mass index and lower WBV. Similar relations were found with hematocrit (data not shown).
We have repeated the analyses shown in this study replacing WBV with hematocrit, a directly measured variable, and found the same results as with WBV (online Tables, see http://hyper.ahajournals.org).
Discussion
The relations between WBV and blood pressure have been assessed in several studies, either in the absence 6 or in the presence of arterial hypertension. 5, 7, 8, 10, 22 In most clinical patient populations, hypertension is associated with relative hyperviscosity, 5, 7, 8, 10, 22 but it is not clear if this is a cause or effect of high blood pressure, 9, 23 or how previous treatment affects this relation. 9, 11 In addition to being part of vascular resistance that thereby directly influences arterial pressure, higher WBV might also be a consequence of high blood pressure caused by increased filtration pressure, leading to hemoconcentration 24 -26 or to direct deterioration of rheological variables. 23 Of note, Tarazi et al 25 reported that increased hematocrit, a major cause of elevated WBV, occurred primarily at diastolic pressures Ն105 mm Hg. A more recent hypothesis is that high WBV and hypertension are not directly linked but instead share inciting genetic and/or environmental factors, including obesity, physical inactivity, and cigarette smoking. 11 In apparent contrast with previous reports, 27 the present study found that arterial hypertension was not associated with WBV estimated using a regression equation including both hematocrit and total plasma proteins 6 or with measured hematocrit. A weak negative association was found between WBV and systolic pressure, similar to our findings in normal individuals, 6 which was consistent with the predominance of normotensive individuals (81%) in the present population from the Strong Heart Study cohort. Because of lack of relation with diastolic blood pressure, we focused our attention on the relation of WBV to pulse pressure, which reflects both lower arterial compliance and greater stroke volume. 28, 29 In our results, independent of covariates (Tables 3 and 4) , high pulse pressure was independently associated with lower blood viscosity and hematocrit.
In normotensive participants, WBV confirmed independent negative relation with pulse pressure, suggesting that in the absence of hypertension (and therefore of arterial structural alterations), pulse pressure might be positively related to magnitude of stroke volume. In contrast, in arterial hypertension this relation is masked. There are at least 2 possible reasons for this difference from normal. First, pressure natriuresis in untreated hypertensive adults can counterbalance the negative pulse pressure-WBV relation found in normotensive individuals. Second, when the cardiovascular system is more compromised, as in the presence of combined high blood pressure, obesity, and diabetes, pulse pressure is likely to be more influenced by the pressure burden imposed on the arterial tree and the arterial stiffness thereof. The differing results in the Oklahoma participants also suggests a genetic influence or/and an effect of unmeasured environmental variables. There are many potential reasons for the apparent inconsistency with previous clinical reports of a direct relation between arterial hypertension and increased WBV. One aspect, already mentioned, is that the hypertensive group was selected on the basis of absence of antihypertensive treatment and of overt cardiovascular disease. The hypertension of this untreated group of subjects was substantially systolic, a condition known to be associated with increased arterial stiffness. 30, 31 Previous studies used mainly diastolic pressure to diagnose hypertension (ie, a measure mostly related to increased peripheral resistance and therefore expected to be related to higher WBV and hematocrit). The hypertensive group in the present study had only relatively mild hypertension, probably without substantial modifications of renal hemodynamics. 24 -26 A recent investigation in a population sample of unselected hypertensive patients found a clear positive relationship between hypertension and blood viscosity, but their average diastolic blood pressure was substantially higher (93 mm Hg) than in the present population (82 mm Hg), 10 suggesting that pressure-dependent hyperfiltration might have influenced this relation. 24 -26 Another important aspect is that our hypertensive subjects were untreated, whereas many participants in most previous clinical studies received antihypertensive therapy. Antihypertensive therapy may affect blood viscosity by: (1) inducing diuresis and causing hemoconcentration (diuretics were the most used antihypertensive agents at the time of data collection of many studies); and (2) directly influencing red blood cell filterability. 7, 32 Antihypertensive treatment has been shown to decrease both WBV and blood pressure, indepen- dently of the class of drug, [33] [34] [35] [36] supporting the possibility that pressure natriuresis contributes to the WBV-blood pressure association. In contrast, diuretic therapy tends to increase WBV, at least in the early phase of treatment, 37, 38 whereas the offsetting effect of reduced pressure hyperfiltration may overcome this effect in the long-term. Also, therapeutic washout may rapidly increase blood pressure and pressuredependent filtration, thereby causing at least transient hemoconcentration.
The present analysis was performed in a Native American population with high prevalences of obesity and type 2 diabetes and peculiar genetic characteristics that might also influence WBV pattern. As compared with values in a white population-based survey conducted in Italy, 21 using the same equations to generate WBV from hematocrit and plasma proteins (4.2Ϯ0.3 cP in women and 4.9Ϯ0.4 cP in men), American Indians exhibits lower average values (4.0Ϯ0.5 cP in women and 4.4Ϯ0.5 cP in men) because of an average lower hematocrit (41Ϯ4% and 44Ϯ5% versus 42Ϯ3% and 47Ϯ3%, in women and men, respectively). This difference is in part caused by different selection criteria of populations (for instance exclusion of lowest hematocrit values and diabetes in Italian participants) but might also reflect genetic differences. Thus, replication of the present findings in other populations with high prevalence of obesity and diabetes is needed.
Limitations of the Study
The main limitation of this study is that WBV was not directly measured and the equation used in this study is validated in an ethnically different population. Erythrocyte aggregability and impaired erythrocyte deformability may influence the magnitude of WBV, 7, 32, 39, 40 as may other less-studied components. 13 Increased red blood cell aggregability and shear resistance of red blood cell aggregates have been proposed to play a role in the development of cardiovascular complications in hypertension. 8 However, the effect of plasma protein concentration (which determines plasma viscosity) and, especially, hematocrit on WBV are much stronger than red blood cell aggregability and deformability. 6 Because the effect of hematocrit in this study paralleled that of WBV, it is unlikely that a significant ethnical bias could have occurred. The balance among rheological components may also be disturbed by other unmeasured factors. 10 This cross-sectional study also cannot assess WBV or hematocrit variation within individuals because of physiological and seasonal factors. Whether this time-related imprecision might have influenced results cannot be determined from the present data.
Finally, in this population sample, most participants were women with abdominal fat distribution, whereas intraabdominal fat is related to blood pressure but is found predominantly in men. 41 Thus, despite the results in multiple linear regression analysis, this sex distribution and prevalence of central obesity should be taken into account when interpreting these results.
Perspectives
This study suggests that the interrelations between WBV and blood pressure levels are complex. Future research on rheological and structural components of peripheral resistance in different ethnic groups and in the setting of never-treated hypertensive subjects with either diastolic or systolic hypertension might help clarifying whether WBV and/or hematocrit should be considered cofactors of altered peripheral resistance or markers of circulating volume status and the extent to which renal hemodynamic influence this relation in the presence of high blood pressure. 
